Moreover, the severity of vascular Aβ deposition in AD patients (i.e., Aβ angiopathy) is associated with lower expression of perivascular AQP4 [86], suggesting a link between impaired glymphatic function and toxic protein accumulation. The gene discussed is AQP4; the disease is Alzheimer disease.